{{Rsnum
|rsid=4988515
|Gene=IGFBP1
|Chromosome=7
|position=45893001
|Orientation=plus
|GMAF=0.07943
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IGFBP1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 84.4 | 15.6 | 0.0
| HCB | 98.5 | 1.5 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 62.8 | 31.7 | 5.5
| ASW | 66.1 | 32.1 | 1.8
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.0 | 1.0 | 0.0
| GIH | 88.8 | 11.2 | 0.0
| LWK | 65.1 | 32.1 | 2.8
| MEX | 84.5 | 13.8 | 1.7
| MKK | 72.5 | 26.1 | 1.3
| TSI | 92.2 | 7.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19858071
|Title=Common Genetic Variation in IGF1, IGFBP1, and IGFBP3 and Ovarian Cancer Risk
|OA=1
}}

{{PMID Auto
|PMID=21140206
|Title=IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families
}}

{{PMID Auto
|PMID=17300730
|Title=Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
|OA=1
}}

{{PMID Auto
|PMID=18596909
|Title=IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|OA=1
}}

{{PMID Auto
|PMID=19551864
|Title=Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
|OA=1
}}

{{PMID Auto
|PMID=19961594
|Title=Power of multifactor dimensionality reduction and penalized logistic regression for detecting gene-gene interaction in a case-control study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}